This inventor holds 2 USPTO granted patents. Top assignees: Teijin Limited, Teijin Pharma Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Toshihiro Ishii: Innovator in GSK-3 Inhibitors
Introduction
Toshihiro Ishii is a notable inventor based in Hino, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit GSK-3 inhibitory activity. With a total of 2 patents to his name, Ishii's work is paving the way for potential therapeutic advancements.
Latest Patents
Ishii's latest patents include innovative compounds such as substituted pyrrolo[3,2-d]pyrimidine derivatives. These compounds are designed to have GSK-3 inhibitory activity, which is crucial for treating various medical conditions. The invention provides pyrrolo[3,2-d]pyrimidine derivatives represented by a specific formula, along with their medically acceptable salts. The compounds are expected to be beneficial in treating conditions like diabetes, Alzheimer's disease, neurodegenerative diseases, and cancer.
Career Highlights
Throughout his career, Toshihiro Ishii has worked with prominent companies such as Teijin Pharma Limited and Teijin Limited. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Ishii has collaborated with notable colleagues, including Takaharu Tsutsumi and Akira Nakano. These partnerships have likely enhanced his research and development efforts in creating effective therapeutic agents.
Conclusion
Toshihiro Ishii's contributions to the field of medicinal chemistry, particularly through his patents on GSK-3 inhibitors, highlight his role as an influential inventor. His work has the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
